Brief: Pharming Group Q1 Net Income USD -5.2 Million
07/05/2026 06:00
May 7 (Reuters) - Pharming Group NV PHAR.AS: PHARMING GROUP Q1 OPERATING PROFIT USD -4.9 MILLION PHARMING GROUP Q1 NET INCOME USD -5.2 MILLION PHARMING GROUP Q1 GROSS PROFIT USD 65.8 MILLION Q1 2026 TOTAL REVENUES DECREASE 8% TO $72.4 MILLION REAFFIRMS 2026 TOTAL REVENUE GUIDANCE OF $405-$425 MILLION, 8%-13% GROWTH GENERATES POSITIVE NET CASH FLOW FROM OPERATIONS OF $2.0 MILLION IN Q1 2026 Source text: ID:nGNE9cQLfP Further company coverage: PHAR.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharming NV
See all newsPharming shares plunge on declining Ruconest sales
Netherlands' Pharming Group prelim Q1 revenue falls on lower RUCONEST sales
Brief: Pharming Group Q1 Net Income USD -5.2 Million
Brief: EMA's CHMP Recommends Extension Of Therapeutic Indication For Pfizer's Hympavzi
Brief: Pharming Group NV Receives Positive CHMP Opinion for Joenja